• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳腺肿瘤的显微荧光分级:一项初步研究。

Microfluorometric grading of mammary tumors. A pilot study.

作者信息

Patek E, Johannisson E, Krauer F, Riotton G

出版信息

Anal Quant Cytol. 1980 Dec;2(4):264-71.

PMID:6258463
Abstract

Material obtained from 24 women with benign and malignant breast lesions was subjected to comparative morphologic and cytophotometric DNA analysis. All the cases of benign tumors, as well as benign tissue samples obtained from tumor-containing breasts, exhibited DNA values corresponding to the diploid control value. The tumors classified as carcinoma in situ or highly differentiated invasive cancers (grade I) showed a distribution of the DNA values significantly different from the diploid control values. The tumors classified s grade II and III showed a shift to the "triploid" area or were totally aneuploid. The results of the present pilot study suggest that quantitative cytophotometric DNA analysis can be used for grading the malignancy of breast tumors in combination with conventional histologic examination. Additional studies of larger groups of women may yield further information on the microfluorometric grading of malignancy. Such studies may also contribute to the further development and use of automated methods of cytologic diagnosis.

摘要

从24名患有良性和恶性乳腺病变的女性身上获取的材料进行了形态学和细胞光度学DNA分析比较。所有良性肿瘤病例以及从含肿瘤乳房获取的良性组织样本,其DNA值均与二倍体对照值相符。被归类为原位癌或高分化浸润性癌(I级)的肿瘤,其DNA值分布与二倍体对照值有显著差异。被归类为II级和III级的肿瘤显示向“三倍体”区域偏移或完全为非整倍体。本初步研究结果表明,定量细胞光度学DNA分析可与传统组织学检查相结合用于乳腺肿瘤恶性程度分级。对更多女性群体的进一步研究可能会提供有关恶性程度微荧光分级的更多信息。此类研究也可能有助于细胞诊断自动化方法的进一步发展和应用。

相似文献

1
Microfluorometric grading of mammary tumors. A pilot study.乳腺肿瘤的显微荧光分级:一项初步研究。
Anal Quant Cytol. 1980 Dec;2(4):264-71.
2
Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.女性乳腺原位癌。一项临床病理、免疫组织化学及DNA倍体研究。
APMIS Suppl. 2003(108):1-67.
3
Cytophotomeric DNA-analysis of aspirated cells from prostatic carcinoma.前列腺癌吸出细胞的细胞光度DNA分析
Acta Cytol. 1976 Jan-Feb;20(1):46-57.
4
Cytochemical classification of nonpalpable breast carcinoma.不可触及性乳腺癌的细胞化学分类
Anal Quant Cytol. 1983 Mar;5(1):9-12.
5
Usefulness of cytofluorometric DNA ploidy analysis in distinguishing benign cartilaginous tumors from chondrosarcomas.细胞荧光DNA倍体分析在鉴别良性软骨肿瘤与软骨肉瘤中的应用价值。
Mod Pathol. 1999 Sep;12(9):863-72.
6
The DNA profile of breast cancer in situ.原位乳腺癌的DNA图谱。
Eur J Surg Oncol. 1992 Apr;18(2):108-11.
7
Ductal lavage findings in women with known breast cancer undergoing mastectomy.接受乳房切除术的已知乳腺癌女性的导管灌洗结果。
J Natl Cancer Inst. 2004 Oct 20;96(20):1510-7. doi: 10.1093/jnci/djh283.
8
Molecular evidence for progression of microglandular adenosis (MGA) to invasive carcinoma.微腺性腺病(MGA)进展为浸润性癌的分子证据。
Am J Surg Pathol. 2009 Apr;33(4):496-504. doi: 10.1097/PAS.0b013e31818af361.
9
The clinical relevance of ploidy and S-phase fraction determination in salivary gland tumors: a flow cytometric study of 97 cases.唾液腺肿瘤中倍体和S期分数测定的临床相关性:97例病例的流式细胞术研究
Cancer. 1999 Jan 15;85(2):273-81.
10
DNA ploidy in screening-detected non-palpable mammary carcinomas.筛查发现的不可触及性乳腺癌中的DNA倍体
Eur J Surg Oncol. 1990 Dec;16(6):471-4.